Cloud-clone
SKU:PAL643Hu01
Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)
Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)
Couldn't load pickup availability
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
Product No.
PAL643Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPL643Hu01-Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
Mus musculus (Mouse), Sus scrofa; Porcine (Pig)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against EGFL7. It has been selected for its ability to recognize EGFL7 in immunohistochemical staining and western blotting.
USAGE
Western blottin:g: 0.5-5µg/mL;
Immunohistochemistry: 5-50µg/mL;
Immunocytochemistry: 5-50µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab PMC5443778 |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. pubmed:28539619 |
| International Journal of Clinical and Experimental Pathology | EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells ISSN:1936-2625 |
| Cancer Drug Resist | MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPL643Hu01 | Recombinant EGF Like Domain Protein, Multiple 7 (EGFL7) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAL643Hu01 | Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) | WB; IHC; ICC; IP. |
| MAL643Hu21 | Monoclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7) | WB; IHC; ICC; IP. |
| SEL643Hu | ELISA Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LML643Hu | Magnetic Luminex Assay Kit for EGF Like Domain Protein, Multiple 7 (EGFL7) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
| PGL643Hu01 | Primer Pair for EGF Like Domain Protein, Multiple 7 (EGFL7) | PCR |
Share
